Previous Close | 4.2500 |
Open | 4.2500 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 4.2500 - 4.2500 |
52 Week Range | 2.5062 - 5.5500 |
Volume | 100 |
Avg. Volume | 533 |
Market Cap | 7.212B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group") is pleased to announce its interim results for the six months ended 30 June 2020. For the current period, the Group recorded a revenue of RMB12,590 million, an increase of 12.6% year-on-year, and profit attributable to shareholders of RMB2,314 million, an increase of 23.2% year-on-year. Basic earnings per share was RMB30.97 cents. The Board of Directors has declared an interim dividend of HK6 cents per share for 2020 and proposed a bonus issue.
Last week, you might have seen that CSPC Pharmaceutical Group Limited (HKG:1093) released its quarterly result to the...
Dividend paying stocks like CSPC Pharmaceutical Group Limited (HKG:1093) tend to be popular with investors, and for...